List Title | APhA DrugInfoLine

Focus on Asthma Care

SORT BY: Most Recent Most Viewed

December 8, 2015

New strategies to improve asthma control in children

READ

PREVIEW
A new review focuses on strategies to improve asthma control in children, such as electronic monitoring devices to improve adherence, on-demand dosing of inhaled corticosteroids (ICSs), a...
September 1, 2015

Albuterol inhaler costs soared after FDA ban on CFC inhalers

READ

PREVIEW
Among privately insured patients, FDA’s ban on chlorofluorocarbon (CFC) albuterol inhalers resulted in higher out-of-pocket costs and modest declines in inhaler use, according to results of a new...
August 5, 2015

Community pharmacists play key role in reducing asthma-related morbidity

READ

PREVIEW
Calculation of the pharmacy-level asthma medication ratio (Ph–AMR), defined as controller medication fills divided by controller plus rescue medication fills, can help predict childhood asthma–...
February 2, 2015

Patients’ beliefs about alternative meds linked to poor asthma control

READ

PREVIEW
Among urban minority adults, negative beliefs about inhaled corticosteroids (ICSs) and positive views about complementary and alternative medicine (CAM) were associated with uncontrolled asthma...
January 21, 2015

Asthma: Adherence improves with reminders, feedback

READ

PREVIEW
Inhaler reminders and feedback were more effective at improving adherence with asthma controller medications compared with behavioral interventions or usual care, according to data published in...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.